<code id='560639BC6B'></code><style id='560639BC6B'></style>
    • <acronym id='560639BC6B'></acronym>
      <center id='560639BC6B'><center id='560639BC6B'><tfoot id='560639BC6B'></tfoot></center><abbr id='560639BC6B'><dir id='560639BC6B'><tfoot id='560639BC6B'></tfoot><noframes id='560639BC6B'>

    • <optgroup id='560639BC6B'><strike id='560639BC6B'><sup id='560639BC6B'></sup></strike><code id='560639BC6B'></code></optgroup>
        1. <b id='560639BC6B'><label id='560639BC6B'><select id='560639BC6B'><dt id='560639BC6B'><span id='560639BC6B'></span></dt></select></label></b><u id='560639BC6B'></u>
          <i id='560639BC6B'><strike id='560639BC6B'><tt id='560639BC6B'><pre id='560639BC6B'></pre></tt></strike></i>

          hotspot

          hotspot

          author:knowledge    Page View:74
          Rep. Cathy McMorris Rodgers (R-WA), chair of the House Energy and Commerce Committee, speaks during a press conference alongside Rep. Brett Guthrie (R-KY) (L) and Rep. Morgan Griffith (R-VA) (R) at the U.S. Capitol Building on July 11, 2023 in Washington, DC. – politics and policy coverage from STAT
          Energy and Commerce Chair Cathy McMorris-Rodgers (R-Wash.) Anna Moneymaker/Getty Images

          WASHINGTON — A House subcommittee took a first step Thursday toward legislation to fix drug shortages at hospitals. Don’t expect a new law soon, though.

          Asked if he expects the House to pass a bill on the subject this year, Energy and Commerce health subcommittee Chair Brett Guthrie (R-Ky.) said drug shortages are an emergency, “but the proposals that have been offered aren’t going to fix it by tomorrow or the next day.”

          advertisement

          “So what we want to do is make sure to fix it as quickly as we possibly can, but do it in a way that’s going to work,” Guthrie said.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          How should state employee insurance handle Wegovy?
          How should state employee insurance handle Wegovy?

          AdobeThisarticleispartofapartnershipbetweenFirstOpinionandTradeoffs, apodcastexploringourconfusing,c

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

          YichuanCao/SipaUSAGileadSciencessaidMondayitwillacquireCymaBayTherapeuticsfor$4.3billion,addinganewt